These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 10165268)
1. Question of ethics. HMOs establish protocols for 'last chance' treatments. Kertesz L Mod Healthc; 1997 Mar; 27(10):106, 108. PubMed ID: 10165268 [No Abstract] [Full Text] [Related]
2. Experimental medical treatments: who should decide coverage? Collins JC Spec Law Dig Health Care Law; 1998 Jan; (226):9-45. PubMed ID: 10176412 [No Abstract] [Full Text] [Related]
3. Evaluating new medical technology: science or politics? Noe TJ HMO; 1995; 36(4):48-53. PubMed ID: 10166486 [No Abstract] [Full Text] [Related]
4. The soul of an HMO. Larson E Time; 1996 Jan; 147(4):44-52. PubMed ID: 10153782 [No Abstract] [Full Text] [Related]
5. When an insurer calls your treatment experimental. Holoweiko M Med Econ; 1995 Sep; 72(17):171-2, 175-6, 178-82. PubMed ID: 10151340 [No Abstract] [Full Text] [Related]
6. Perspectives. Indefinite results in ABMT (autologous bone marrow transplantation) trials add to challenges for practice standards, quality assurance in cancer care. Cunningham R Med Health; 1999 Apr; 53(16):suppl 1-4. PubMed ID: 10387749 [No Abstract] [Full Text] [Related]
7. The limited regulatory potential of medical technology assessment. Elhauge E Va Law Rev; 1996 Nov; 82(8):1525-1622. PubMed ID: 16715565 [No Abstract] [Full Text] [Related]
8. Investigational treatments: coverage, controversy, and consensus. Ader M Ann Health Law; 1996; (5):45-60. PubMed ID: 10164521 [No Abstract] [Full Text] [Related]
9. Managing ethics in managed care. Friedman E Healthc Forum J; 1989; 32(2):9-10. PubMed ID: 10292199 [No Abstract] [Full Text] [Related]
10. Will insurers pay for high-tech care? Crane M Med Econ; 1991 Apr; 68(8):82-6. PubMed ID: 10110091 [No Abstract] [Full Text] [Related]
11. Experimental treatment: can you do the right thing without going broke? Holoweiko M Bus Health; 1995 May; 13(5):38-40, 45-6, 48. PubMed ID: 10164496 [No Abstract] [Full Text] [Related]
12. Substitutions and rebates: questionable materiel management practices in HMOs? Summers J J Healthc Mater Manage; 1993 Aug; 11(7):54-5. PubMed ID: 10131843 [No Abstract] [Full Text] [Related]
13. The cancer wars at HMOs. Brink S US News World Rep; 1996 Feb; 120(5):69-70. PubMed ID: 10154338 [No Abstract] [Full Text] [Related]
14. Health insurance: coverage of autologous bone marrow transplantation for breast cancer. Jaggar SF Oncology (Williston Park); 1996 Sep; 10(9):1329-32, 1337-8, 1340 passim. PubMed ID: 8882925 [No Abstract] [Full Text] [Related]
15. HMOs under the knife. The capital races to crack down on managed care. Fineman H Newsweek; 1998 Jul; 132(4):21. PubMed ID: 10182683 [No Abstract] [Full Text] [Related]
19. Ethics. The view from HMOs. Hosp Health Netw; 1998 Apr; 72(7):15. PubMed ID: 9582899 [No Abstract] [Full Text] [Related]
20. The mandate for investigational cancer therapies. Brown E Physician Exec; 1995 Sep; 21(9):46-7. PubMed ID: 10151483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]